BELATACEPT

2852 reported adverse events

Drug classes: Selective T Cell Costimulation Blocker [EPC]

These side effects are most commonly reported by patients taking BELATACEPT:

# Side effect Count
0 OFF LABEL USE 199
1 DEATH 173
2 KIDNEY TRANSPLANT REJECTION 172
3 TRANSPLANT REJECTION 133
4 CYTOMEGALOVIRUS INFECTION 90
5 ACUTE KIDNEY INJURY 83
6 INTENTIONAL PRODUCT USE ISSUE 82
7 SEPSIS 78
8 HOSPITALISATION 77
9 PYREXIA 77
See all common reactions for BELATACEPT

BELATACEPT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE MESANGIAL SCLEROSIS 3 0.2143
1 HERPES SIMPLEX MENINGITIS 8 0.1600
2 PYELONEPHRITIS FUNGAL 5 0.1351
3 REMOVAL OF RENAL TRANSPLANT 4 0.0952
4 DISSEMINATED BLASTOMYCOSIS 3 0.0938
5 BK POLYOMAVIRUS TEST POSITIVE 4 0.0930
6 GRAFT LOSS 42 0.0694
7 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 12 0.0591
8 POLYOMAVIRUS TEST POSITIVE 6 0.0550
9 EYE INFECTION TOXOPLASMAL 13 0.0489
See all enriched reactions for BELATACEPT